<DOC>
	<DOCNO>NCT00902213</DOCNO>
	<brief_summary>This first multidisciplinary , randomize , longitudinal trial tailor , parent- child-focused physical activity program child ( age 4- &lt; 19 year ) newly diagnose ALL . It test ability intervention prevent diminish early physical function limitation improve health-related quality life ( HRQL ) . The intervention test effect : 1 ) physical function outcome ( muscle strength , range motion , endurance , gross motor skill ) , bone density bone mineral content ( end therapy ) ; 2 ) HRQL . This multi-site trial test intervention 76 evaluable child ALL ( 38 receive intervention 38 receiving placebo `` minimal movement '' standard care strategy ) .</brief_summary>
	<brief_title>Physical Activity Modify Sequelae Quality Life Childhood Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>An advanced practice nurse ( APN ) meet twice weekly patient family first 4 week intervention initiate motivation-based dialogue therapeutic interaction ; follow weekly visit week 5-8 intervention ; monthly visit week 9-through end therapy . The physical therapist ( PT ) meet least weekly patient family week 1-4 initiate prescriptive tailor exercise program ; subsequent visit reinforce modify program occur least every week week 5-8 , least monthly week 9-135 intervention . The PT visit least weekly week 1-4 , least every week week 5-8 , least monthly week 9-135 . During week 9-135 intervention , APN call monthly person-visits , need randomized MAP group assure fidelity intervention provide booster support intervention need .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>1 . An immunophenotypic diagnosis nonB cell ALL 2 . Age 4 year &lt; 19 year diagnosis 3 . 28 day per front line ALL treatment protocol 4 . One parent legal guardian ( ≥ 18 year ) study subject speak understands English Language 5 . Participant speak understands English language 6 . Written inform consent child assent 1 . Age &lt; 4 year ≥19 year diagnosis 2 . A diagnosis cerebral palsy syndrome 3 . Second malignancy , chromosome breakage syndrome , severe congenital immunodeficiency 4 . Inability unwillingness research participant legal guardian/representative give write informed consent/assent 5 . Females pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>